Intercept Pharma (ICPT) Ticks Higher Ahead of Expected FDA Briefing Docs on OCA in PBC
Tweet Send to a Friend
Intercept Pharma (Nasdaq: ICPT) shares are trading higher Monday as investors are expecting ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
